BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1751952)

  • 1. Large-scale production of human tumorcytotoxic macrophages grown from blood monocytes of cancer patients.
    Brugger W; Scheibenbogen C; Krause S; Andreesen R
    Cancer Detect Prev; 1991; 15(5):407-12. PubMed ID: 1751952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy.
    Andreesen R; Scheibenbogen C; Brugger W; Krause S; Meerpohl HG; Leser HG; Engler H; Löhr GW
    Cancer Res; 1990 Dec; 50(23):7450-6. PubMed ID: 1701343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to adoptive immunotherapy of cancer using tumorcytotoxic macrophages grown from peripheral blood monocytes.
    Andreesen R; Scheibenbogen C; Brugger W; Krause S; Leser HG; Kopf S; Engler H; Schümichen C; Löhr GW
    Cancer Detect Prev; 1991; 15(5):413-21. PubMed ID: 1751953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic characterisation of human peritoneal and alveolar macrophages and of human blood monocytes differentiated in the presence of either GM-CSF or M-CSF or a combination of GM-CSF/M-CSF.
    Eischen A; Vincent F; Louis B; Schmitt-Goguel M; Bohbot A; Bergerat JP; Oberling F
    Nouv Rev Fr Hematol (1978); 1992; 34(6):421-34. PubMed ID: 1300541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of human macrophages with potent antitumor properties (MAK) by culture of monocytes in the presence of GM-CSF and 1,25-dihydroxy vitamin D3.
    Chokri M; Lopez M; Oleron C; Girard A; Martinache C; Canepa S; Siffert JC; Bartholeyns J
    Anticancer Res; 1992; 12(6B):2257-60. PubMed ID: 1295473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity.
    Young DA; Lowe LD; Clark SC
    J Immunol; 1990 Jul; 145(2):607-15. PubMed ID: 2142182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the dependence of human monocytes and macrophages antitumoral properties upon TNF-alpha expression or release.
    Dumont S; Mabondzo A; Hartmann D; Gilgenkrantz JL; Kessler R; Poindron P; Bartholeyns J
    Anticancer Res; 1990; 10(4):949-54. PubMed ID: 2116753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
    Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
    Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
    Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
    Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-cytolytic human macrophages cultured as nonadherent cells: potential for the adoptive immunotherapy of cancer.
    Helinski EH; Hurley EL; Streck RJ; Bielat KL; Pauly JL
    Cancer Detect Prev; 1990; 14(4):471-81. PubMed ID: 2224910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor and accessory immune activities of peripheral blood stem cells mobilized with granulocyte-macrophage colony-stimulating factor.
    Triozzi PL; Tucker F; Benzies T; Balcerzak SP
    Bone Marrow Transplant; 1996 Jul; 18(1):47-52. PubMed ID: 8831995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusion of large quantities of autologous blood monocyte-derived macrophages in two cancer patients did not induce increased concentration of IL-6, TNF-alpha, soluble CD14 and nitrate in blood plasma.
    Lopez M; Louvet C; Martinache C; Bony V; Scotto F; Barelaud S; Jiang R; Drapier JC; Smadja V; De Gramont A
    Eur Cytokine Netw; 1994; 5(4):411-4. PubMed ID: 7531001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human blood-derived macrophages: differentiation in vitro of a large quantity of cells in serum-free medium.
    Vincent F; Eischen A; Bergerat JP; Faradji A; Bohbot A; Oberling F
    Exp Hematol; 1992 Jan; 20(1):17-23. PubMed ID: 1577091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender dimorphism of macrophage response to GMCSF and IL-4 for differentiation into dendritic cells.
    Gupta V; Singh SM
    Am J Reprod Immunol; 2008 Jul; 60(1):43-54. PubMed ID: 18593437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human recombinant granulocyte-macrophage colony-stimulating factor and IL-3 on the expression of surface markers of human monocyte-derived macrophages in long-term cultures.
    Dimri R; Nissimov L; Keisari Y
    Lymphokine Cytokine Res; 1994 Aug; 13(4):239-45. PubMed ID: 7528061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
    Motohashi S; Nagato K; Kunii N; Yamamoto H; Yamasaki K; Okita K; Hanaoka H; Shimizu N; Suzuki M; Yoshino I; Taniguchi M; Fujisawa T; Nakayama T
    J Immunol; 2009 Feb; 182(4):2492-501. PubMed ID: 19201905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant granulocyte-macrophage colony-stimulating factor augments viability and cytotoxic activities of human monocyte-derived macrophages in long-term cultures.
    Robin G; Markovich S; Athamna A; Keisari Y
    Lymphokine Cytokine Res; 1991 Aug; 10(4):257-63. PubMed ID: 1932369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.